The association of erythropoiesis-stimulating agent resistance index (ERI), serum fetuin-A with butyrylcholinesterase in hemodialysis patients

The association of erythropoiesis-stimulating agent resistance index (ERI), serum fetuin-A with butyrylcholinesterase in hemodialysis patients - The association of erythropoiesis-stimulating agent resistance index (ERI), serum fetuin-A with butyrylcholinesterase in hemodialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000028064

Enrollment

250

Registered

2017-07-06

Start date

2017-07-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease with hemodialysis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hemodialysis patients in Oyokyo kidney research institute Aomori hospital

Exclusion criteria

Exclusion criteria: patients with active infection, autoimmune disease, active hepatitis, liver cirrhosis, and obvious cancerous cachexia.

Design outcomes

Primary

Measure	Time frame
To investigate the degree of correlationship between ERI,serum fetuin-A level and serum butyrylcholinesterase level	—

Secondary

Measure	Time frame
To determine multiple liner regression equation of fetuin-A and ERI	—

Countries

Japan

Contacts

Public ContactTeppei Okamoto

Hirosaki University School of Medicine Urology

uroyone@hirosaki-u.ac.jp0172395091

Outcome results